| Name | Title | Contact Details |
|---|---|---|
John Kelly |
Chief Information Officer | Profile |
Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of prescription medicines for pets in the United States and Europe. It develops AT-001, a prostaglandin E receptor 4 antagonist to treat the pain and inflammation associated with osteoarthritis in dogs, as well as for the management of pain in cats; AT-002, a potent and selective ghrelin agonist for the stimulation of appetite in cats and dogs; and AT-003, a bupivacaine liposome injectable suspension to manage post-operative pain in cats and dogs following surgery. The company was founded in 2010 and is headquartered in Kansas City, Kansas.
Aspen Center for Integrative Health is a Aspen, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Otsuka America is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HighMark BLueCross BlueShield is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Putnam County Operation Life is a Greencastle, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.